CellaVision ABCVLLY +12.06%69 OCF Margin % is 37.52% as of Mar. 2026, which is 37% above its 10-year median of 27.36. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, CellaVision AB ranks better than 90.18% on this metric.
The historical rank and industry rank for CellaVision AB's OCF Margin % or its related term are showing as below:
CVLLY'
s OCF Margin % Range Over the Past 10 Years
Min: 15.09 Med: 27.36 Max: 29
Current: 27.58
During the past 13 years, the highest OCF Margin % of CellaVision AB was 29.00%. The lowest was 15.09%. And the median was 27.36%.
CVLLY's OCF Margin % is ranked better than 90.18% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs CVLLY: 27.58
CellaVision AB OCF Margin % Related Terms
CellaVision AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for CellaVision AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CellaVision AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellaVision AB OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where CellaVision AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellaVision AB (CVLLY) has a OCF Margin % of 37.52% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CellaVision AB and its competitors. This is 37% above median its historical median of 27.36. Over the past decade, CellaVision AB's OCF Margin % has ranged from 15.09 to 29.00. According to the industry distribution chart, CellaVision AB ranks #80 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 9.8%.
Is CellaVision AB's OCF Margin % too high?
CellaVision AB's current OCF Margin % of 37.52% is 37% above median its 10-year median of 27.36. Over the past 10 years, this metric has ranged from a low of 15.09 to a high of 29.00. The Medical Devices & Instruments industry median OCF Margin % is 5.86. CellaVision AB's value of 37.52% is 540.3% above this industry median. Based on the distribution chart, CellaVision AB ranks #80 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #80 out of 815 companies for OCF Margin %. This places CellaVision AB in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. CellaVision AB's value of 37.52% is 540.3% above this benchmark. Historically, CellaVision AB's own OCF Margin % has ranged from 15.09 to 29.00 over the past decade. While the company's 10-year median is 27.36 vs. the industry median of 5.86, CellaVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current OCF Margin % of 37.52% is 540.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current OCF Margin % is 37.52%, which is 37% above median its own 10-year median of 27.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current OCF Margin % is 37.52%, which is 37% above median its 10-year median of 27.36 and 540.3% above the Medical Devices & Instruments industry median of 5.86. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current OCF Margin % is 37.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellaVision AB (CVLLY) Overvalued in 2026?
Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued.
The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48.
GuruFocus considers CellaVision AB to be Significantly Undervalued.
Key valuation signals for CVLLY:
OCF Margin %: 37.52% (37% above median its 10-year median of 27.36)
GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
Industry Position: 540.3% above the Medical Devices & Instruments median (#80 of 815)
No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
69GF Score
Get the complete analysis for CVLLY
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVLLY has been successfully added to your 
